Board of Directors


William S. Woulfin (Chairman)

William “Bill” Woulfin has 30 years of management and operations experience in the telecommunications and healthcare industries. Prior to MET-TEST, his most recent experience includes five years as Chairman/CEO of LecStar Telecom, Inc., a competitive local exchange carrier in Atlanta, Georgia. Prior to LecStar, Bill spent twenty-two years as the Executive Vice President of Computer Generation Incorporated (CGI) holding numerous positions responsible for worldwide sales, marketing, and new product evaluation. Bill also served as the Chairman of Conference World Wide for two years. Bill participated in the successful sale of all three of these companies. Bill joined MET-TEST in 2003 and has been driving the expansion and growth of the company through his vision and leadership. Bill is very active in charitable organizations including holding the positions of District Chairperson for the Rotary Foundation Major Gifts Program for 2001 and 2002, Director and 2004 Past President of the Dunwoody Rotary Club, and the 2007 Past District Governor of District 6900 of Rotary International. Bill received an Electrical Engineering degree from Case Institute of Technology in Cleveland, Ohio.

  • David O. Ellis

    Dr. David Ellis was born in the United Kingdom, where he received a British Petroleum scholarship to the University of St. Andrews. He earned an Honours degree in Chemistry, followed by a Ph.D. in Biophysics. After university, he joined 3i Group PLC, one of the largest private equity managers in the world. After attending the Senior Executive Program at the Sloan School of MIT, he was responsible for 3i’s technology and turnaround investments. While at 3i, Dr. Ellis had oversight over several hundred private equity investments. In 1988, David and Sal Massaro launched EGL Ventures, a venture capital and private equity business. Based on David’s relationships in British finance circles, they raised capital for EGL’s U.S. investments from Mercury Asset Management plc, the private equity division of The National Westminster Bank and other U.S. institutional and high net worth investors. EGL has invested four funds in a wide range of sectors, including information technology, healthcare, instrumentation, manufacturing, and distribution businesses, and at all stages of development. All investments in Funds I through III have been realized. Dr. Ellis has also held numerous operational and advisory roles in the U.K. and the U.S.: COO and CEO of B.H. Blackwell Ltd. (Oxford, England), the world’s largest distributor of library materials. CFO of Software Sciences International Ltd. (London, England), a computer systems group specializing in defense systems, air traffic control and newspaper automation. Member of Board of Directors of Oxford Instruments plc, where Dr Ellis was instrumental in commercializing the superconducting magnet technology used in today’s modern MRI imaging equipment. Dr Ellis has been very active in the Atlanta community since his arrival in 1979. Dr. Ellis co-founded the MIT Enterprise Forum of Atlanta and, in 1998, received the Georgia Technology Forum award for “Outstanding Contribution to the Technology Industry.” He currently serves on the Board of Speedtracs, Information Access Management, and the Advisory Boards of the College of Sciences at The Georgia Institute of Technology, The Shepherd Center, The Pedowitz Group, Echo 11, Neural Signals Inc. and two Rehabilitation Engineering Research Centers. David’s memberships include the Technology Association of Georgia, the Technology Executive Roundtable, the British-American Business Group, and the Atlanta Venture Forum.

  • John Mohr


    John is a multi-dimensional drug industry executive with expertise in managing emerging company issues. His distinguished career includes management of multi-million dollar brands and building products from ‘bench-to-market’. His experience includes 12 years at Merck where he lead Financial Services for Merck’s North America Operations followed by six years of responsibility in Marketing & New Product Planning for CNS and GI Products, including worldwide marketing franchise head for the blockbuster brand - Pepcid®. He was President of Fournier Pharma (US) where he was responsible operations including clinical development, regulatory and business development. He built a strategic partnership with Abbott for TriCor®, now a $1.5 billion CV brand. Most recently he led Business and Corporate Development at CV Therapeutics resulting in a major agreement with the European company Menarini and subsequently managing the $1.4 billion M&A transaction with Gilead. John possesses a portfolio of worldwide contacts and provides significant experience in closing successful licensing and M&A.

  • Joseph Allegra, MD


    J C Allegra, MD Age 62 Atlanta Georgia Married ( Marilyn ) 3 children / BA from Temple University ( Chemistry ) 1970 / MD from Penn State University//Hershey Medical Center 1974 / Internship and Residency Internal Medicine 1974-1976 Hershey Medical Center / Fellowship Medical Oncology NIH/NCI Bethesda MD 1976-1978 /Senior Investigator NIH/NCI 1978-1980 /Military USPHS 1976-1980 Lt Cmdr / Professor and Chairman of Department of Medicine at University of Louisville 1982-1989 / Ended academic career in 1989 and moved to Atlanta Georgia to become President of T-2 Medical a physician centric Home Health Company Responsible for revenue growth between 1989 and 1993 from 50M to 300M and for listing T-2 on NYSE. Post T-2 functioned as President of OTI a Division of PhyMatrix which was a physician management company in Florida. Left PhyMatrix in 1997 to form NMCR a physician oriented education company and from 1997--2006 led the growth of NMCR to the largest oncology oriented education company in the USA prior to its purchase by Amerisource Bergen. Since 2006, I have functioned as the owner of Lincoln Lee Investments, LLC a family owned investment organization oriented to Health Care Investments Serve on numerous Public and Private Boards and am the author of over 100 publications in peer reviewed medical publication.

  • Sundeep Chaudhry, MD


    Dr. Sundeep Chaudhry is the clinical thought leader for MET-TEST. He spent four years in a private clinic practicing general medicine, noninvasive cardiology, echocardiography and stress testing and has served as chairman of the department of medicine at Emory Dunwoody Medical Center. During his years of medical training and private practice, Dr. Chaudhry developed a keen interest in preventive cardiology and non-invasive diagnostic cardiology. That interest has turned into a relentless pursuit of utilizing cardiopulmonary exercise technology (CPET) and integrating this information with other test data to set a new standard for improving cardiac disease management and patient outcomes. Dr. Chaudhry is a graduate of the Georgia Institute of Technology where he received a Bachelor of Science degree in Chemistry with honors. He went on to earn his medical degree from the Medical College of Georgia with post-graduate residency training in internal medicine at Emory University. He has publications in cardiology and general medicine journals and is involved in peer review.

  • William J. Hudson Jr.


    Retired Vice Chairman, CEO/President AMP Incorporated. After graduating as an Electrical Engineer from Cornell University, was commissioned an Ensign in the US Navy, served on the USS Phillip in the Western Pacific and at Pearl Harbor. After the US Navy, joined Leeds & Northrup Co. in Philadelphia in their General Management Training Program and was then assigned to Research in developing the first solid state computer for process control. Studied at night at Drexel to gain an MBA. After L&N joined AMP Incorporated, worked for the top management planning committee, ran three product development groups, received eleven patents, then ran an SBU followed by assignments as a Group VP, Asia/Pacific regional VP, Executive VP International and then CEO/President. Retired after thirty eight years with AMP. Held positions in the Business Round Table, NAM, PBEC, Global Business Policy Council as well as Board positions in various non-profits. Served on the Boards of AMP, Goodyear Tire & Rubber, Carpenter Technology, Keithley Electrical Instruments and Elderport. Currently serve on the boards of Applied Systems Intelligence and Metabolic Testing Services.

  • Salvatore Massaro (Observer)


    Sal Massaro has been a General Partner at EGL Ventures since he and David Ellis founded the EGL venture capital and private equity business in 1988. Since 1988, EGL has raised four funds, including a Cayman Islands Limited Partnership to house fund investments from The National Westminster Bank plc and Mercury Asset Management plc, EGL’s principle historical overseas investors, and a Small Business Investment Company (“SBIC”) which was approved by the SBA to draw leverage. In addition to his fundraising and investment responsibilities, Sal has been the CFO of all of the funds entities, the liaison to the Small Business Administration (“SBA”) for the SBIC for over ten years, and the primary investor liaison. EGL provides debt and equity capital to finance growth, business recapitalizations and change of control transactions. The firm has generated an IRR in excess of 23% since inception. Mr. Massaro has had responsibility for minority and majority investments in a broad range of industries including business services, information technology, instrumentation, healthcare, consumer goods and telecommunications. As a Board Member/Observer of EGL portfolio companies, Mr. Massaro has provided advice on strategic, financial and operational challenges to companies at all stages of development. Sal began his career in the management consulting group of Price Waterhouse in New York City in 1978. In this role, he advised clients on their financial management information systems, and on mergers and acquisition activities. Representative clients included Corning Glass Works, Drexel Burnham Lambert, and The Ford Foundation. In 1982, he took an operational role as CFO of Telesphere International, a supplier of long-distance and operator-assisted telephone service and telecommunications equipment to the hotel industry. He was responsible for all finance, accounting, tax, and investor affairs of the company, completing a mezzanine round of venture capital and managing the company’s initial public offering through D.H. Blair & Co. At the time, he was the youngest CFO of a publicly-traded company in the United States. Before leaving Telesphere, Mr. Massaro financed the company’s entry into the long-distance business by raising secured debt capital through Chemical Bank and through a secondary public offering managed by Smith Barney & Co.